Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on June 10, 2025
Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split
GlobeNewswire
·
June 10, 2025
CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced a reverse stock split of its issued and outstanding …
Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution
GlobeNewswire
·
June 10, 2025
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new collaboration with Amazon’s Health Benefits Connector to expand access to comprehensive women’s …
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
GlobeNewswire
·
June 10, 2025
BERKELEY, Calif. and MAINZ, Germany, June 10, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announces the commencement of …
Roji Health Intelligence Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity
GlobeNewswire
·
June 10, 2025
CHICAGO, June 10, 2025 (GLOBE NEWSWIRE) -- Roji Health Intelligence LLC, a leading provider of Value-Based Care technology and services to health care providers, today announced that its Roji Clinical Data Registry, ”Roji Registry”, has earned certified …
Ensemble and Cohere Launch End-to-End Agentic AI Platform for Integrated Revenue Cycle Orchestration
GlobeNewswire
·
June 10, 2025
CINCINNATI, Ohio, June 10, 2025 (GLOBE NEWSWIRE) -- Ensemble, the industry leader in end-to-end revenue cycle management (RCM), today announced the launch of a transformational agentic AI platform for RCM in partnership with Cohere, the leading security- …
Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension
GlobeNewswire
·
June 10, 2025
NORCROSS, Ga., June 10, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will host a virtual …
Iovance Biotherapeutics to Present at Upcoming Conference
GlobeNewswire
·
June 10, 2025
SAN CARLOS, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
GlobeNewswire
·
June 10, 2025
MALVERN. Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …
MetaVia to Present at the Life Sciences Virtual Investor Forum June 12th
GlobeNewswire
·
June 10, 2025
CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon Kim, President and Chief Executive Officer will …
Rose Hill Life Sciences to Spotlight Leading Research Partners at Psychedelic Science 2025
GlobeNewswire
·
June 10, 2025
Dr. Gül Dölen, MD, PhD, to share groundbreaking research on how psychedelic compounds can reopen “critical periods” of brain plasticity. Rotem Petranker, PhD, to discuss the latest findings from controlled clinical trials investigating the effects of …
Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology
GlobeNewswire
·
June 10, 2025
Ness-Ziona, Israel, June 10, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present a poster at the European Alliance of …
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium
GlobeNewswire
·
June 10, 2025
SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present …
Vivani Medical to Present at the 2025 BIO International Convention
GlobeNewswire
·
June 10, 2025
ALAMEDA, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, …
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
GlobeNewswire
·
June 10, 2025
Dr. Michael Vasconcelles brings more than 25 years of extensive oncology research, development and health technology expertise and corporate executive leadership to Day One Dr. Vasconcelles to drive pipeline creation and execution BRISBANE, Calif., June 10 …
Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
GlobeNewswire
·
June 10, 2025
ISELIN, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the Scottish Medicines …
Noom Expands Board of Directors with Appointment of Global Health Leader Dr. David Luu
GlobeNewswire
·
June 10, 2025
Dr. Luu’s experience as a visionary heart surgeon and longevity health-tech entrepreneur positions him to support Noom’s long-term strategic mission NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to …
Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt
GlobeNewswire
·
June 10, 2025
Ashvattha will present Phase 2 data on migaldendranib, a subcutaneous therapy for DME and wet AMD, which could offer a more patient-friendly alternative to current injection-based treatments Company is exploring new technology to normalize VEGF expression, …
MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions
GlobeNewswire
·
June 10, 2025
CARMEL, Ind., June 10, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
GlobeNewswire
·
June 10, 2025
BENGALURU, India, June 10, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic …
BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego
GlobeNewswire
·
June 10, 2025
BURLINGTON, Mass. and JERUSALEM, June 10, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …